Critical Issues in Head and Neck Oncology Key Concepts from the Sixth THNO Meeting /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Vermorken, Jan B. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Budach, Volker (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Leemans, C. René (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Machiels, Jean-Pascal (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Nicolai, Piero (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), O'Sullivan, Brian (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
• Έκδοση: 1st ed. 2018.
• Θέματα: Oncology .; Radiotherapy.; Cancer research.; Oncology.; Cancer Research.

This book provides an overview of the latest advances in head and neck cancer using a multidisciplinary approach. Commencing with a discussion of epidemiological and diagnostic aspects, including the role of vaccination and key pathological features, the book then follows by examining the role of on...

Πίνακας περιεχομένων:

• Part I. Epidemiology and diagnosis
• The role of vaccination in head and neck cancer prevention
• Cellular and molecular pathology in head and neck cancer
• Part II. Prediction of outcome
• Oncogenomics/proteomics of head and neck cancer
• Targeted next-generation sequencing in head and neck cancer
• Homologous recombination function as predictor of treatment response
• Part III. Oral cavity cancer
• Surgical management of oral cavity cancer
• Reconstruction in oral cavity cancer: when and how
• Induction chemotherapy: does it have a place in oral cavity cancer?
• Are there alternative local treatments in oral cavity cancer?
• Part IV. Oropharynx cancer
• HPV assessment in oropharynx cancer: what is the gold standard?
• A new staging system for oropharynx cancer and why?
• Should we de-escalate the treatment in HPV-positive oropharynx cancer?
• Is there a new role for surgery in oropharynx cancer?
• Can we expect less toxicity with newer forms of radiation?
• Part V. Miscellaneous topics
• What is the optimal larynx preservation approach and who are the candidates?
• Is the approach to patients with unknown primary tumors any different in 2017?
• Cytotoxic chemotherapy and targeted therapy in nasopharynx cancer
• Are there alternative chemotherapy regimens for EXTREME in recurrent/metastatic SCCHN
• New data on systemic therapy of salivary gland tumors
• Treatment of elderly patients with head and neck cancer
• Part VI. Thyroid cancer
• World-wide thyroid cancer epidemics: what is going on?
• The surgical approach to thyroid cancer in 2017
• Part VII. Keynote address
• Immunology and immunotherapy in head and neck cancer
• .